Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study

References

• TadinTKrpinaKŠtifterSBabarovićEJonjićNSignificance of uroplakin III expression in recurrence of solitary muscle non-invasive bladder cancerPathol Res Pract2014210527928424553301
   PubMedGoogle Scholar
• FuDLiPChengWImpact of vascular endothelial growth factor gene-gene and gene-smoking interaction and haplotype combination on bladder cancer risk in Chinese populationOncotarget2017814229272293528206971
   PubMedGoogle Scholar
• QiDLiJQueBLong non-coding RNA DBCCR1-003 regulate the expression of DBCCR1 via DNMT1 in bladder cancerCancer Cell Int2016168127777512
   PubMed Web of Science ®Google Scholar
• XiaoJLinHYZhuYYZhuYPChenLWMiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathwayOnco Targets Ther201695181519327578985
   PubMed Web of Science ®Google Scholar
• GilDCiołczyk-WierzbickaDDulińska-LitewkaJLaidlerPIntegrin-linked kinase regulates cadherin switch in bladder cancerTumour Biol20163711151851519127683053
   PubMedGoogle Scholar
• WuZWangCZhangZHigh expression of Derlin-1 is associated with the malignancy of bladder cancer in a Chinese Han populationPLoS One20161112e016835127977784
   PubMed Web of Science ®Google Scholar
• CuiXShenDKongCNF-kB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivoSci Rep201774072328139689
   PubMed Web of Science ®Google Scholar
• HeideggerITulchinerGSchäferGHorningerWPichlerRLong term disease free survival with multimodal therapy in small cell bladder cancerEur J Med Res20162114027737712
   PubMedGoogle Scholar
• YuYLiXLiangCThe relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysisMedicine (Baltimore)20169537e490027631264
   PubMedGoogle Scholar
• DuJWangSHYangQChenQQYaoXp53 status correlates with the risk of progression in stage T1 bladder cancer: a meta-analysisWorld J Surg Oncol20161413727129876
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• VashisthaVQuinnDIDorffTBDaneshmandSCurrent and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic reviewBMC Cancer20141496625515347
   PubMedGoogle Scholar
• MalmströmPUWijkströmHLundholmCWesterKBuschCNorlénBJ5-year followup of a randomized prospective study comparing mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma. Swedish-Norwegian Bladder Cancer Study GroupJ Urol199916141124112710081852
   PubMed Web of Science ®Google Scholar
• TsujiSChenXHancockBPreclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancerMol Ther Oncolytics201631600427119118
   PubMed Web of Science ®Google Scholar
• YeFWangLCastillo-MartinMBiomarkers for bladder cancer management: present and futureAm J Clin Exp Urol20142111425374904
   PubMedGoogle Scholar
• BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
   PubMed Web of Science ®Google Scholar
• BartelDPChenCZMicromanagers of gene expression: the potentially widespread influence of metazoan microRNAsNat Rev Genet20045539640015143321
   PubMed Web of Science ®Google Scholar
• HuangYLiXTaoGZhuTLinJComparing serum microRNA levels of acute herpes zoster patients with those of postherpetic neuralgia patientsMedicine (Baltimore)2017968e599728225487
   PubMedGoogle Scholar
• WangCLiaoHCaoZRole of osterix and microRNAs in bone formation and tooth developmentMed Sci Monit2016222934294227543160
   PubMed Web of Science ®Google Scholar
• ZhouYLXuYJQiaoCWMiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathwayInt J Clin Exp Pathol2015866312632226261507
   PubMedGoogle Scholar
• YangGZhangXShiJMiR-98 inhibits cell proliferation and invasion of non-small cell carcinoma lung cancer by targeting PAK1Int J Clin Exp Med2015811201352014526884926
   PubMed Web of Science ®Google Scholar
• KimVNMicroRNA biogenesis: coordinated cropping and dicingNat Rev Mol Cell Biol20056537638515852042
   PubMed Web of Science ®Google Scholar
• ShiMLiuDDuanHShenBGuoNMetastasis-related miRNAs, active players in breast cancer invasion, and metastasisCancer Metastasis Rev201029478579920938719
   PubMedGoogle Scholar
• LuJGetzGMiskaEAMicroRNA expression profiles classify human cancersNature2005435704383483815944708
   PubMed Web of Science ®Google Scholar
• GuoJXiaBMengFLouGmiR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptorTumour Biol20143521557156424127040
   PubMed Web of Science ®Google Scholar
• DongYZhaoJWuCWTumor suppressor functions of miR-133a in colorectal cancerMol Cancer Res20131191051106023723074
   PubMed Web of Science ®Google Scholar
• CuiWZhangSShanCZhouLZhouZmicroRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathwayFEBS J2013280163962397423786162
   PubMedGoogle Scholar
• KojimaSChiyomaruTKawakamiKTumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancerBr J Cancer2012106240541322068816
   PubMed Web of Science ®Google Scholar
• ZhangWLiuKLiuSJiBWangYLiuYMicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinomaTumour Biol201536129779978826156803
   PubMedGoogle Scholar
• ChenXBoLZhaoXChenQMicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinomaMol Med Rep20151153900390725607810
   PubMed Web of Science ®Google Scholar
• ZhouYWuDTaoJQuPZhouZHouJMicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancerScand J Urol201347542343223206218
   PubMed Web of Science ®Google Scholar
• SongTXiaWShaoNDifferential miRNA expression profiles in bladder urothelial carcinomasAsian Pac J Cancer Prev201011490591121133599
   PubMedGoogle Scholar
• IchimiTEnokidaHOkunoYIdentification of novel microRNA targets based on microRNA signatures in bladder cancerInt J Cancer2009125234535219378336
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• TangZLiCKangBGaoGLiCZhangZGEPIA: a web server for cancer and normal gene expression profiling and interactive analysesNucleic Acids Res Epub2017412
   Web of Science ®Google Scholar
• PignotGCizeron-ClairacGVacherSmicroRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancerInt J Cancer2013132112479249123169479
   PubMed Web of Science ®Google Scholar
• YoshinoHChiyomaruTEnokidaHThe tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancerBr J Cancer2011104580881821304530
   PubMed Web of Science ®Google Scholar
• HanYChenJZhaoXMicroRNA expression signatures of bladder cancer revealed by deep sequencingPLoS One201163e1828621464941
   PubMed Web of Science ®Google Scholar
• ZhuJJiangZGaoFA systematic analysis on DNA methylation and the expression of both mRNA and microRNA in bladder cancerPLoS One2011611e2822322140553
   PubMedGoogle Scholar
• HigginsJThompsonSDeeksJAltmanDStatistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practiceJ Health Serv Res Policy200271516111822262
   PubMedGoogle Scholar
• SchmidCHStarkPCBerlinJALandaisPLauJMeta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factorsJ Clin Epidemiol200457768369715358396
   PubMed Web of Science ®Google Scholar
• UchidaYChiyomaruTEnokidaHMiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell linesUrol Oncol201331111512321396852
   PubMed Web of Science ®Google Scholar
• WeiYHeRWuYComprehensive investigation of aberrant microRNA profiling in bladder cancer tissuesTumour Biol2016379125551256927350368
   PubMedGoogle Scholar
• ChiyomaruTEnokidaHTataranoSmiR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancerBr J Cancer2010102588389120160723
   PubMed Web of Science ®Google Scholar
• YamasakiTYoshinoHEnokidaHNovel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancerInt J Oncol20124061821183022378464
   PubMedGoogle Scholar
• HouYDengJZhangLLower expression of PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1) association with poor prognosis of gastric cancerInt J Clin Exp Med2015811204812048926884964
   PubMedGoogle Scholar
• Ter BraakBSiezenCLLeeJSInsulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass productionBreast Cancer Res20171911428173837
   PubMedGoogle Scholar
• QayyumTFyffeGDuncanMThe interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladderBr J Cancer201210661187119522353809
   PubMedGoogle Scholar
• ChenGFangTHuangZMicroRNA-133a inhibits osteosarcoma cells proliferation and invasion via targeting IGF-1RCell Physiol Biochem201638259860826845446
   PubMedGoogle Scholar
• ZhuZXuTWangLMicroRNA-145 directly targets the insulin-like growth factor receptor I in human bladder cancer cellsFEBS Lett2014588173180318524999188
   PubMed Web of Science ®Google Scholar
• KhotskayaYBGoverdhanAShenJS6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancerAm J Transl Res20146436137625075253
   PubMed Web of Science ®Google Scholar
• FleckensteinDSDirksWGDrexlerHGQuentmeierHTumor necrosis factor receptor-associated factor (TRAF) 4 is a new binding partner for the p70S6 serine/threonine kinaseLeuk Res200327868769412801526
   PubMedGoogle Scholar
• de GrootRPBallouLMSassone-CorsiPPositive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen-induced gene expressionCell199479181917923380
   PubMed Web of Science ®Google Scholar
• HergovichAStegertMRSchmitzDHemmingsBANDR kinases regulate essential cell processes from yeast to humansNat Rev Mol Cell Biol20067425326416607288
   PubMedGoogle Scholar
• HergovichARegulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signallingCell Biosci2013313223985307
   PubMed Web of Science ®Google Scholar
• ColeARPCTK proteins: the forgotten brain kinases?Neurosignals200917428829719816065
   PubMedGoogle Scholar
• YanagiTKrajewskaMMatsuzawaSReedJCPCTAIRE1 phosphorylates p27 and regulates mitosis in cancer cellsCancer Res201474205795580725205104
   PubMed Web of Science ®Google Scholar
• YanagiTReedJCMatsuzawaSPCTAIRE1 regulates p27 stability, apoptosis and tumor growth in malignant melanomaOncoscience201411062463325593992
   PubMedGoogle Scholar
• YanagiTMatsuzawaSPCTAIRE1/PCTK1/CDK16: a new oncotarget?Cell Cycle201514446346425590439
   PubMed Web of Science ®Google Scholar
• LiTZhaoJYangJA meta-analysis of the association between ESR1 genetic variants and the risk of breast cancerPLoS One2016114e015331427070141
   PubMedGoogle Scholar
• LyuXYangJWangXA novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemiaMol Cytogenet201694727350795
   PubMedGoogle Scholar
• BreyerJWirtzRMLaibleMESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC)Virchows Arch2016469554755227514658
   PubMed Web of Science ®Google Scholar
• HardieDGAlessiDRLKB1 and AMPK and the cancer-metabolism link – ten years afterBMC Biol2013113623587167
   PubMedGoogle Scholar
• LiangJMillsGBAMPK: a contextual oncogene or tumor suppressor?Cancer Res201373102929293523644529
   PubMed Web of Science ®Google Scholar
• SteinbergGRKempBEAMPK in health and diseasePhysiol Rev20098931025107819584320
   PubMed Web of Science ®Google Scholar
• ViolletBHormanSLeclercJAMPK inhibition in health and diseaseCrit Rev Biochem Mol Biol201045427629520522000
   PubMed Web of Science ®Google Scholar
• WiklundEDBramsenJBHulfTCoordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancerInt J Cancer201112861327133420473948
   PubMed Web of Science ®Google Scholar
• ZhuBQiLLiuSCLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumorBMC Cancer201717110528166762
   PubMedGoogle Scholar
• WangXLiangZXuXmiR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancerCell Death Dis2016712e250327906180
   PubMed Web of Science ®Google Scholar
• RatertNMeyerHAJungMReference miRNAs for miRNAome analysis of urothelial carcinomasPLoS One201276e3930922745731
   PubMed Web of Science ®Google Scholar
• XuCZengQXuWmiRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTORMol Cancer Ther201312220721923270926
   PubMedGoogle Scholar
• MeiriELevyABenjaminHDiscovery of microRNAs and other small RNAs in solid tumorsNucleic Acids Research201038186234624620483914
   PubMed Web of Science ®Google Scholar
• AmiraNCancel-TassinGBernardiniSExpression in bladder transitional cell carcinoma by real-time quantitative reverse transcription polymerase chain reaction array of 65 genes at the tumor suppressor locus 9q34.1-2: identification of 5 candidates tumor suppressor genesInt J Cancer2004111453954215239131
   PubMedGoogle Scholar